4716 related articles for article (PubMed ID: 6169659)
1. Lymphocyte-dependent antibodies to antigen 3.1, a cell-surface antigen expressed by a subgroup of human melanomas.
Hellström I; Hellström KE; Yeh MY
Int J Cancer; 1981 Mar; 27(3):281-5. PubMed ID: 6169659
[TBL] [Abstract][Full Text] [Related]
2. Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside.
Hellström I; Brankovan V; Hellström KE
Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1499-502. PubMed ID: 3856277
[TBL] [Abstract][Full Text] [Related]
3. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
5. The human natural killer cytotoxic cell line NK-92, once armed with a murine CD16 receptor, represents a convenient cellular tool for the screening of mouse mAbs according to their ADCC potential.
Clémenceau B; Vivien R; Pellat C; Foss M; Thibault G; Vié H
MAbs; 2013; 5(4):587-94. PubMed ID: 23770975
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.
Hellström I; Beaumier PL; Hellström KE
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7059-63. PubMed ID: 3462743
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
[TBL] [Abstract][Full Text] [Related]
8. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
Rupniewska ZM; Adamczyk MB
Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
[No Abstract] [Full Text] [Related]
9. Production and characterization of monoclonal antibodies against human malignant melanoma.
Herlyn M; Steplewski Z; Herlyn D; Clark WH; Ross AH; Blaszczyk M; Pak KY; Koprowski H
Cancer Invest; 1983; 1(3):215-24. PubMed ID: 6667406
[TBL] [Abstract][Full Text] [Related]
10. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
Kan-Mitchell J; White WL; Mitchell MS
Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
Herlyn D; Herlyn M; Steplewski Z; Koprowski H
Eur J Immunol; 1979 Aug; 9(8):657-9. PubMed ID: 499332
[TBL] [Abstract][Full Text] [Related]
13. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
Christiaansen JE; Burnside SS; Sears DW
J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
[TBL] [Abstract][Full Text] [Related]
14. Clonal variation in expression of a human melanoma antigen defined by a monoclonal antibody.
Yeh MY; Hellström I; Hellström KE
J Immunol; 1981 Apr; 126(4):1312-7. PubMed ID: 7009737
[TBL] [Abstract][Full Text] [Related]
15. Higher cytolytic efficiency of an IgG2 alpha than of an IgG1 monoclonal antibody reacting with the same (or spatially close) determinant on a human high-molecular-weight melanoma-associated antigen.
Imai K; Pellegrino MA; Wilson BS; Ferrone S
Cell Immunol; 1982 Sep; 72(2):239-47. PubMed ID: 6185235
[No Abstract] [Full Text] [Related]
16. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
Johnson JP; Riethmüller G
Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
[TBL] [Abstract][Full Text] [Related]
17. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
Plain MJ; Whitehead RH; Jose DG
Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
[TBL] [Abstract][Full Text] [Related]
18. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.
Kipps TJ; Parham P; Punt J; Herzenberg LA
J Exp Med; 1985 Jan; 161(1):1-17. PubMed ID: 3918141
[TBL] [Abstract][Full Text] [Related]
19. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis.
Cheresh DA; Honsik CJ; Staffileno LK; Jung G; Reisfeld RA
Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5155-9. PubMed ID: 3860849
[TBL] [Abstract][Full Text] [Related]
20. Characterization of monoclonal antibodies to human melanoma-associated antigens.
Imai K; Ng AK; Ferrone S
J Natl Cancer Inst; 1981 Mar; 66(3):489-96. PubMed ID: 6162991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]